Hjem › Småcellet lungekreft › District of Columbia › Washington
Kliniske studier for Småcellet lungekreft i Washington, DC
12 studier for Småcellet lungekreft søker deltakere på steder i og rundt Washington (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease
RekruttererFase 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors
RekruttererObservasjonsstudie
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
RekruttererFase 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
RekruttererFase 1
- Georgetown University Medical Center, Washington D.C.
A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
RekruttererFase 1/2
- Site 1001, Washington D.C.
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
RekruttererFase 3
- Maryland Oncology Hematology, Silver Spring · 7 mi unna
- American Oncology Partners, PA - The Center for Cancer and Blood Disorders, Bethesda · 7 mi unna
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
RekruttererFase 1/2
- Avenzo Therapeutics Recruiting Site, Washington D.C.
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
RekruttererFase 2
- Georgetown Lombardi Cancer Center, Washington D.C.
Lurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER)
RekruttererFase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
RekruttererFase 1/2
- National Institutes of Health, Bethesda · 7 mi unna
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
RekruttererFase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi unna
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
RekruttererFase 1/2
- The George Washington University Cancer Center (site 212), Washington D.C.
Småcellet lungekreft-studier i andre byer
- Houston, TX26 studier
- Arlington, VA23 studier
- New York City, NY22 studier
- Boston, MA21 studier
- Nashville, TN20 studier
- Los Angeles, CA20 studier
- Orlando, FL15 studier
- Dallas, TX13 studier
- Cleveland, OH13 studier
- Chicago, IL13 studier
- St. Louis, MO13 studier
- Detroit, MI12 studier
Andre studier i Washington
- Kreft (alle typer)58 studier
- Ikke-småcellet lungekreft55 studier
- Brystkreft46 studier
- Metastatisk kreft43 studier
- Lungekreft41 studier
- Prostatakreft38 studier
- Fedme33 studier
- Kolorektal kreft29 studier
- Kardiovaskulær sykdom28 studier
- Blærekreft26 studier
- Akut myelogen leukemi24 studier
- Eggstokkreft23 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.